{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-21-000115","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2021-07-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.922478+00:00","generated_at":"2026-06-30T03:58:15.057402+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Intuitive Surgical Q2 revenue up 72% to $1.46B; GAAP EPS $4.25, non-GAAP EPS $3.92; procedures up 68%","bullets":["Revenue $1.46B (+72% YoY); procedure growth 68% YoY; compound annual growth 16.5% from Q2 2019.","GAAP net income $517M ($4.25 diluted); non-GAAP net income $477M ($3.92 diluted).","Shipped 328 da Vinci systems (+84% YoY); installed base 6,335 (+10% YoY).","Cash and investments $7.7B, up $504M during quarter; generated from operations.","Instruments/accessories revenue $796M (+73%); systems revenue $440M (+68%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-21-000115","json":"https://secwatch.observer/filing/0001035267-21-000115.json","markdown":"https://secwatch.observer/filing/0001035267-21-000115.md","text":"https://secwatch.observer/filing/0001035267-21-000115.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526721000115/0001035267-21-000115-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526721000115/isrg-20210720.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T03:58:15.057402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}